The role of endogenous isoprene in the human body, if any, is unclear because previous research is inconsistent and mechanistic evidence for the biologic function of isoprene is lacking. Given previous evidence that exhaled isoprene is elevated in systemic inflammatory states, we hypothesized that exhaled isoprene would be positively associated with a breath biomarker of airway inflammation, the fractional concentration of exhaled nitric oxide (FE NO ). We examined relationships of exhaled breath isoprene with FE NO and with outdoor ozone given that ozone chemically reacts with isoprene and has been positively associated with FE NO in past studies. Sixteen elderly subjects were followed with ≤12 weekly exhaled hydrocarbon and FE NO collections at the subjects' retirement community. Outdoor ozone concentrations were measured continuously on site. Mixed-effects regression analyses tested relations of FE NO with isoprene, and FE NO and isoprene with ozone, adjusted for temperature. We found FE NO was inversely associated with isoprene, and this was not confounded by ozone. Isoprene was inversely related to ozone. FE NO was positively related to ozone and this relation was not confounded by isoprene. In contrast to hypothesized relations, we conclude that exhaled isoprene is inversely associated with FE NO as well as outdoor ozone, which suggests possible protective ozone-scavenging functions of endogenous isoprene. Findings may indicate chemical reactions of isoprene oxidation by ozone and by hydroxyl radicals in the presence of O 2 that is dependent on NO concentration. These preliminary results need to be confirmed in additional studies of human subjects, particularly as they apply to FE NO monitoring in asthma.
Introduction
A number of volatile organic compounds exist in exhaled human breath, with exhaled isoprene acetone, ethanol, methanol and other alcohols being among the most abundant (Fenske and Paulson 1999) . Measurement of volatile organic compounds (VOCs) in exhaled breath is a non-invasive method of disease or exposure assessment (Pleil and Lindstrom 1997) . Recent studies have found that some of these compounds may prove to be useful as clinical biomarkers of systemic ketosis (Likhodii et al 2002) , acute myocardial infarction (Mendis et al 1994) , oxidative and metabolic stress (Pabst 2004) , and cancer (Schmutzhard et al. 2008) . Breath sulfides have potential as a biomarker of exacerbations in cystic fibrosis patients and methyl nitrate as an indicator of hyperglycemia in children who have insulin dependent diabetes mellitus (Kamboures et al. 2005; Novak et al. 2007) . Exhaled isoprene may function as a useful biomarker of inflammation and has been shown to be produced endogenously (King et al. 2009 and , but its exact functions within the human body, if any, have not yet been established (Salerno-Kennedy and Cahsman 2005) .
While at this stage analysis of exhaled breath for disease biomarkers remains largely investigational, there is great clinical potential for these non-invasive, easily reproducible tests. The fractional concentration of exhaled nitric oxide (FE NO ) is an example of a noninvasive test of airway inflammation and now can be used in certain cases to diagnose and monitor subjects with asthma (Dweik et al. 2011; Jones et al. 2001; Taylor 2012) . FE NO has recently been integrated into clinical practice since it has been found to be associated with asthma control and with established measures of airway inflammation in numerous studies (e.g., Jones et al. 2001) . In 2011, the American Thoracic Society published clinical guidelines on the use of FE NO to assess airway disease (Dweik et al. 2011) . Though FE NO has been used as a clinical biomarker of airway inflammation in patients with asthma, the potential of exhaled volatile hydrocarbons such as isoprene in the same capacity is not clear.
Elevated breath isoprene levels have been reported after smoking cigarettes. Smoking just one cigarette increases isoprene by 70% in exhaled breath (Senthilmohan et al. 2001 ).
Research on isoprene in humans and mammals still remains limited and no clear mechanism pointing to its function, if any, has been elucidated (Salerno-Kennedy and Cashman 2005) . Numerous studies have extrapolated to humans data from mice and rats on isoprene toxicokinetics, however, the differences between these species and humans in terms of metabolism and reactivity of metabolites makes it difficult to predict human toxicokinetics (Watson et al. 2001 ).
Previous studies have hypothesized that exhaled isoprene may be a clinical indicator of mevalonate biosynthesis from hydroxymethylglutaryl-coenzyme A (HMG-CoA, an early step leading to cholesterol synthesis). This was first demonstrated in the in vivo biosynthesis of isoprene from DL-melavonate in the cytosolic fraction of rat liver (Deneris et al. 1985) .
Isoprene is a by-product during the conversion of mevalonate to mevanolate-5-pyrophosphate and isopentenyl pyrophosphate. Interestingly enough, there is some evidence that the use of statins to treat hypercholesterolemia (statins inhibit HMG-CoA reductase that catalyzes production of mevalonate from HMG-CoA) has been associated with reduced levels of isoprene in exhaled breath (Karl et al. 2001; Stone et al. 1993) . Findings of reduced isoprene levels in exhaled breath in those with end stage liver disease has been found to be linked directly to the reduction of serum cholesterol providing further support for the role of isoprene in cholesterol biosynthesis (Sehnert et al. 2002) .
Since cholesterol formation is related to inflammation (Kleeman and Kooistra 2005) and isoprene is a byproduct of cholesterol biosynthesis, there is thus the potential of exhaled isoprene to serve as a marker of inflammation (Salerno-Kennedy and Cahsman 2005) . Numerous studies have found elevated exhaled isoprene levels in humans in acute conditions of inflammation such as acute myocardial infarctions and certain cancers (Salerno-Kennedy and Cahsman, 2005; Likhodii et al. 2002; Mendis et al. 1994; Pabst et al. 2004; Schmutzhard et al. 2008) . Though exhaled isoprene levels were found elevated in patients after undergoing hemodialysis for end stage renal disease, the authors of this study hypothesized that though these results may be due to oxidative stress it may instead be due to Henry's law constant (Lirk et al. 2003 ). Yet, not all studies have found such positive relations between exhaled isoprene and different inflammatory states (Bajtarevic et al. 2009 , Schubert et al. 2005 , McGrath et al. 2001 ) and thus the relationship between exhaled isoprene and inflammation in humans is not well defined.
There is a great need to understand the role of endogenous exhaled isoprene because previous research is inconsistent and mechanistic evidence for the biologic function of isoprene is lacking. In the present pilot study we aimed to investigate the relationship of isoprene in exhaled breath with FE NO to determine if exhaled isoprene may also have potential as a biomarker of airway inflammation. We hypothesized that exhaled isoprene would be positively associated with FE NO . Given our previous findings that the pro-oxidant air pollutant outdoor ozone (O 3 ) is positively associated with FE NO , (Delfino et al. 2010), we also aimed to investigate the relation of O 3 to both FE NO and exhaled isoprene in the present study population.
Methods

Population and design
Data were derived from our study to evaluate the pro-inflammatory and cardiovascular effects of air pollution exposure in four senior assisted living communities (Delfino et al. 2010 ). The present study collected supplemental data from that larger cohort in one of the retirement communities where we collected exhaled breath to analyze hydrocarbons using high resolution methods (described in Methods below). For the present study, 16 elderly subjects were recruited from a senior assisted living community in Riverside, California. In order to be included in the study, the subject had to be 65 years or older, a nonsmoker, without tobacco smoke exposure at home, and with a confirmed history of coronary artery disease (CAD). Those with a diagnosis of CAD were included in the original study as this is a population at potentially high risk from the cardiovascular effects of air pollutants, which was the focus of the parent study. An earlier analysis of FE NO in the larger cohort panel of 60 subjects found positive associations between FE NO and markers of exposure to photochemical oxidant air pollution, including outdoor ozone (Delfino et al. 2010) . FE NO was thus available for evaluation of exhaled isoprene as a potential exhaled breath marker of inflammation. There were 27 volunteers for the retirement community in the present analysis of exhaled breath isoprene, of which 5 were not eligible according the above stated criteria and 6 either dropped out or had insufficient or invalid biomarker data, leaving 16 subjects.
The subjects were followed for 6 weeks in two seasonal periods, for a total of 12 weeks. Measurements were collected once at the same time of day on Fridays of each of the 12 monitored weeks. The overall average number of weeks per subject was 10 and the range was 6-12. The first phase was in September and October 2006, which are warmer months for the study region. The second phase was in January and February 2007, which are cooler months. These two distinct seasonal periods were chosen to enhance differences in photochemical activity where warmer months have higher photochemically-related air pollutants such as outdoor ozone compared to cooler months.
Exhaled NO measurements
Subjects were instructed to refrain from exercise and food and beverage intake for 1 hour prior to exhaled breath sampling. This was done to avoid any possible alterations in FE NO levels that may result from these activities. We collected FE NO using standard offline procedures specified by the American Thoracic Society and European Respiratory Society (2005) and described by us in more detail elsewhere (Delfino et al. 2010 ). Subjects performed a slow vital capacity maneuver into an offline apparatus (Sievers Deadspace Discard Bag Collection & Sampling Kit, Ionics Inc., Boulder, CO) that was attached to a non-reactive 1.5 L Mylar reservoir bag after venting approximately 200 ml of dead-space air. The exhalation flow rate was 100 ml/sec. and was controlled by having the subjects maintain a constant breath pressure of 19 cm H 2 O by monitoring a needle on a pressure gauge. To control for inspired ambient NO, an NO/NO 2 chemisorbent filter was placed at the air intake of the apparatus, and subjects breathed through it for 15 seconds (≥ 2 tidal breaths) before sampling. Furthermore, to control for nasal NO and ambient NO, a nose clip was used to prevent unfiltered air from entering the lungs. Subjects were instructed to keep their mouth tightly around the mouthpiece at all times until the end of test. Samples were collected in triplicate. An indoor air sample was collected using the same equipment and concurrent with the breath sample to assess influence of indoor NO on exhaled NO (there was no influence). Refrigerated (6°C) sealed Mylar bags were analyzed within 20 hours for FE NO concentration with a chemiluminescence NO analyzer (NOA ™ 280i Sievers, GE Analytical Instruments, Boulder, CO). Exhaled NO pairs that were within 2 SD of the within-individual population average were averaged and retained for analysis.
Breath samples were collected in electropolished 1.9 L stainless steel canisters that were fitted with Swagelok Nupro metal Bellow valves (see Figure 1 ). Simultaneous samples of room air for hydrocarbon measurements were taken because levels of hydrocarbons in air can vary greatly during a short period of time and exhaled sample levels of hydrocarbons need to be corrected for inspired levels. Samples of exhaled breath were taken in the same centrally ventilated rooms in both phases of the study. Subjects were directed to take three deep breaths, each time exhaling slowly through the tube, before filling lungs to total capacity and exhaling into the evacuated canister. In order to avoid upper airway contamination of the sample, the initial 2 seconds of the exhaled breath was bypassed at the canister valve and not collected.
Exhaled breath and indoor air hydrocarbon measurements
Breath and room samples were analyzed for hydrocarbons by cryogenic preconcentration and injection (264 cm 3 at STP) into a multi-column/detector chromatography system. This system employed the use of two flame ionization detectors (FID), two electron capture detectors (ECD), and a quadropole mass spectrometer. Trace gases including exhaled isoprene were quantified using five different column/detector combinations: DB-1/FID, PLOT+DB-1/FID, Restek1701/ECD, DB-5+Restek1701/ECD and DB-5 ms/MSD. CO 2 concentrations in breath and room samples were measured using a separate GC system. The samples were analyzed within two weeks of sampling. We have done canister stability studies for a variety of gases, isoprene included, and the loss rate for exhaled isoprene was <1%/week. Exhaled CO 2 was used to normalize exhaled isoprene levels, which along with subtracting room isoprene, produced an estimate of endogenously produced exhaled isoprene. For analysis of CO 2 , aliquots of breath samples were injected onto a Carbosphere 80/100 packed column output to a thermal conductivity detector (TCD). Alveolar gradient concentrations of exhaled gases were calculated by subtracting the background room concentration from the corresponding breath concentration.
Exhaled isoprene levels were expressed as:
To further understand the relation between exhaled isoprene and FE NO , we evaluated the possible role of outdoor ozone. Previous studies in a larger cohort of 60 subjects from which the present study was derived found a positive association between FE NO and outdoor ozone (Delfino et al. 2010) . Although no similar data exists to our knowledge in animal cells, it is of interest that plants release higher concentrations of isoprene when exposed to ozone, thus limiting oxidant damage to their cells (Velikova et al. 2005; Velikova et al. 2008 ).
Hourly outdoor ozone measurements were made at the retirement community where subjects resided. Federal reference methods were used to measure ozone in a mobile air monitoring station located at the outdoor home environment of the community.
Statistical Analysis
Exhaled NO had a skewed distribution and was log transformed to normalize its distribution. Analyses of the relationships between biomarkers of interest (FE NO in relation to exhaled isoprene) were done using linear mixed-effects models allowing a multivariate analysis with individual repeated measures, which are not independent. The focus of the models is on within-individual exposure-response relations. A generalized linear mixed effects model has fixed effect regression coefficients as well as an additional random-effects intercept to account for the clustered within-subject observations. Exhaled isoprene and FE NO levels were analyzed in relation to each other and both in relation to outdoor community levels of 24-hr average ozone over the 5 days leading up to the breath measurements. We adjusted for splines of the 24-hour average of temperature before each breath measurement. This type of smoothing spline was implemented to fit a curve to nonlinear data as can happen with hourly to daily variations in temperature. To account for the possibility of subject outliers influencing the data, analysis of FE NO predicted by exhaled isoprene was repeated after excluding two influential subject clusters that were identified in residual analyses (discussed below). All regression coefficients were standardized to the interquartile (25th -75th) percentile range (IQR) of each predictor variable. Table 1 shows descriptive statistics for study subjects consisting of 13 males and 3 females, all of Caucasian descent. All subjects had a confirmed history of coronary artery disease and were nonsmokers. None of the participants had a confirmed history of diabetes mellitus or asthma; however, one patient did have a diagnosis of chronic obstructive pulmonary disease. Half of the subjects were on statins.
Results
Descriptive data of our variables of interest (exhaled isoprene, FE NO , and 24-hour outdoor ozone) are provided in Table 2 . Exhaled isoprene was normally distributed. As stated in the methods section, FE NO was skewed in an approximately log normal distribution. The intrasubject coefficient of variation for breath CO 2 (not shown) was as little as 5% in one subject (subject average of 4.42% ± 0.24) and as large as 22% in another subject (3.64% ± 0.79). This suggests that our breath sampling method was fairly repeatable within each subject based on the stability of exhaled CO 2 , although some week-to-week variation is expected, thus justifying the CO 2 correction.
In mixed model analyses we found an inverse relation between FE NO and exhaled isoprene, adjusted for 24-hr average temperature splines up to the time of breath measurements. The percent decrease in FE NO predicted by an interquartile range increase in exhaled isoprene was 9.9% with a 95% confidence interval of (−16.9, −2.9), p-value <0.006, where the percent change in FE NO is calculated from [e ( x IQR) −1] × 100%. In analysis of influential clusters for ln (FE NO ) predicted by exhaled isoprene, we identified two influential subject clusters. When one subject cluster was removed it decreased the magnitude of association from −9.9% to −7.4%, but was still significant (p < 0.04, 95% CI: −14.1%, −0.7%). On the other hand, removal of the other subject cluster increased the magnitude to −14.2% as well as the significance of association (p<0.0001, 95% CI: −20.6%, −7.9%). Therefore, the inverse relationship between FE NO and exhaled isoprene remained even after removal of these opposing subject clusters.
A limitation of the breath sampling method is the possibility that residual isoprene in the airways from ambient air is not completely accounted for by subtracting background room concentrations. Therefore, as discussed in the Methods section exhaled isoprene was normalized to exhaled CO 2 (we prefer to express results directly as exhaled isoprene ppt/ ppm CO 2 using the ratio ppt/ppm) to obtain an estimate of endogenously produced exhaled isoprene. This resulted in the reduction of isoprene variability by ~10-20% in most cases. Therefore, we performed a sensitivity analysis using uncorrected exhaled isoprene (but still subtracting background room isoprene) to determine if correcting for CO 2 affected the regression results presented above. The regression results for uncorrected exhaled isoprene showed a major decrease in the percent change of FE NO predicted by an interquartile range increase in isoprene that was only borderline significant (−1.3%, 95% CI: −2.8, 0.13) indicating that our approach may have reduced a major source of error in sample collection. Table 3 describes the results for exhaled isoprene predicted by outdoor community ozone measurements. There was an inverse relation between exhaled isoprene and outdoor ozone levels averaged across different numbers of days, all of which were statistically significant. Table 4 describes the results for changes in FE NO predicted by 24-hour average outdoor community ozone measurements adjusted for splines of 24 hour average temperature. Unlike the relation of FE NO with exhaled isoprene, FE NO and outdoor ozone were positively associated. There also appears to be a multiday cumulative increase in the magnitude of the relation between FE NO and ozone up to the 3-day average of ozone.
Given that ozone is associated with both exhaled isoprene and FE NO , it is possible that ozone could confound the inverse relationship that was found between exhaled isoprene and FE NO . Therefore we compared models unadjusted and adjusted for ozone (Figure 2 ). The inverse relationship between FE NO and exhaled isoprene changed only nominally (<10%) and remained statistically significant. The positive relationship of FE NO with ozone remained as well with exhaled isoprene in the model (<10% change).
As discussed previously, it has been hypothesized that use of statins is associated with a decrease in isoprene levels in exhaled breath (Karl et al. 2001; Stone et al. 1993) . In order to test this hypothesis with our data we performed a linear mixed effect model for change in exhaled isoprene predicted by statins. We unexpectedly found that compared with subjects not taking statins, subjects taking statins had an overall higher exhaled isoprene level of 0.32 ppt/ppm CO 2 (p-value < 0.05, 95% CI: 0.0003, 0.62).
Discussion
The objective of our pilot study was to determine if isoprene in exhaled breath may be a potential clinical biomarker of airway inflammation by assessing its relationship with FE NO , which has already been established as a biomarker of airway inflammation. Interestingly, we observed that instead of a positive relation between exhaled isoprene and FE NO , an inverse relation was found in this group of retirement community subjects with coronary artery disease. These results remained significant when outdoor ozone was included in the regression model. Exhaled isoprene was also found to have an inverse relationship with 24 hour multi-day averages of outdoor ozone. FE NO , as predicted, had a positive relationship with 1-day through 5-day average 24-hour outdoor ozone measurements. This finding is consistent with previous studies that have observed a positive relation of FE NO and ambient ozone in children (Berhane et al. 2011; Delfino et al. 2006 ) and in elderly people (Adamkiewicz et al. 2004; Delfino et al. 2010) . One of these studies (the larger cohort for the present study) additionally found that FE NO was positively associated with both outdoor ozone levels and markers of secondary organic chemicals in PM suggesting oxidized air pollutants in general were important to airway inflammatory responses (Delfino et al. 2010) . Using the same breath hydrocarbon measurements as the present study, Gorham et al. (2009) reported that repeated weekly measurements of ethane and n-pentane were not associated with FE NO but were associated with concentrations of air pollutant gases (NO, NO 2 and CO) in the indoor and outdoor community environment. We concluded that ethane and n-pentane were more likely to be biomarkers of air pollutant exposures not biomarkers of airway inflammation as previously believed.
Speculations regarding these preliminary findings
As previously cited, studies have observed that isoprene may protect plants against short term temperature changes and exposure to ozone. The antioxidant effect of exhaled isoprene may be due to a direct reaction with ozone and other ROS in the gas phase (Logan et al. 2000; Lorezo and Velikova 2001) . Isoprene has also been reported to quench NO either by direct scavenging of NO or ONOO− or by lowering the oxidative burst resulting in less NO (Velikova 2005; Velikova 2009; Sharkey and Yeh 2011) . This may have led to the reduced damage observed in ozonated leaves by modifying NO-triggered hypersensitivity and cell death responses after ozone exposure (Sharkey and Yeh 2011) .
In contrast to our finding of a negative relation between outdoor ozone and exhaled isoprene, an experimental study found that in six human subjects exposed experimentally to high ozone (to 350 ppb) during exercise, isoprene increases significantly 19 ± 1 hours after ozone exposure as compared with filtered air (Foster et al. 1996) . These ozone levels are a magnitude higher than the present study. Authors hypothesized that damage to cell membranes by ozone could be followed by increased sterol synthesis and compensatory increases in isoprene.
We speculate that in humans, isoprene may also play a role as an antioxidant. Like in plants, isoprene may scavenge for reactive oxygen species. In particular it may react with H 2 O 2 and peroxynitrite (ONOO−) in the lungs, which are the products of the oxidation of NO by superoxide anion (O 2 −). This may explain why research on isoprene in humans has found that exhaled isoprene levels correlate with acute inflammation. Subjects who had acute myocardial infarctions, subjects immediately after sternotomy from cardiac surgery, and subjects with a higher cardiac index have been found to have elevated exhaled isoprene levels (Mendis et al. 1995; Pabst et al. 2007) . Patients who were diagnosed with head and neck tumors were also found to have elevated levels of isoprene in exhaled breath compared to subjects in a control group, a high risk group, as well as a post therapy group (Schmutzhard et al. 2008) .
The function of isoprene may also be explained in terms of a chemical reaction in humans rather than a biological mechanism. Isoprene reacts with the OH radical, NO 3 radical, Cl radical, and O 3 . The OH-radical initiated oxidation of isoprene is responsible for 50-100% of ambient air ozone production attributed to VOC oxidation in the United States. In addition to ozone, this oxidation of isoprene in the atmosphere is responsible for a significant portion of secondary organic aerosol formation. These reactions can cause NO to form alkoxy radicals in the presence of molecular oxygen. Through a series of experiments, it has been demonstrated that there is OH cycling in isoprene oxidation. There is a timedependent formation of OH as a function of O 2 and NO. Thus, oxidation of isoprene in the presence of O 2 is dependent on NO concentration (Ghosh et al., 2010 ).
Origination of Exhaled isoprene
As stated earlier in the introduction, via experimental modeling, exhaled isoprene has been shown to originate endogenously in humans. This was demonstrated in a studies performed by King et al. (2009 and in which real time measurements of exhaled isoprene were collected under ergometer challenges. Although isoprene is involved in cholesterol biosynthesis, their results support that there is a peripheral tissue source of isoprene in humans which is linked to local gas exchanges. Both studies performed ergometer challenges using leg exercises (pedaling). The latter of the two studies found a rise and peak of exhaled isoprene that correlated with cardiac output, alveolar ventilation, and ventilation perfusion ratio. When both legs were exercised, exhaled isoprene levels decreased and leveled off to baseline levels during the exercise. This indicates that there may possibly be a reserve of isoprene that became depleted. However, when only one leg was used at a time, another peak of exhaled isoprene was noted when subjects switched their legs. The authors note that the exact tissue groups involved in the origin of exhaled isoprene remains unknown but hypothesize that the skeletal locomotor muscles and/or the vascular tree are involved due to high blood flow during exercise (King et al., 2010) . Since our subjects were at rest at each and every weekly repeated measurement, this source of exhaled isoprene should not have affected our results.
Limitations
Although our study had a limited number of subjects we were able to collect repeated measures for each subject for our statistical analysis in which essentially each subject acts as their own control over time. Nevertheless, the sample size of 16 subjects limits the generalizability of the results. As stated previously, numerous studies have proposed that isoprene is a by-product of mevalonate biosynthesis. The small number of subjects using statins (8 subjects) did limit our ability in analyzing between-subject differences in exhaled isoprene levels predicted by statin use and may explain our non-significant and unexpected results showing generally higher levels of exhaled isoprene among subjects taking statins. Another limitation of this study is that even though we had outdoor air samples to measure ozone levels we did not have personal exposure assessments. Personal exposure assessments allow a more accurate measurement of exposure of an individual. Given the potential influence of physical activity on isoprene levels, another limitation of the present study is the lack of activity monitoring data. This in turn, could have also biased our results although all subjects were tested at rest during the exhaled breath testing after sitting in the clinic intake area. Also, although subjects may have hyperventilated while providing a breath sample, it is unlikely since we had the subjects breath in and out deeply 3 times and then blow out slowly. Furthermore, intra-individual CO 2 values as described in the methods section were found to be fairly consistent and if a subject was hyperventilating, they would have done that with each weekly measurement. As mentioned above, normalizing isoprene by CO 2 reduced the overall coefficient of variation by 15.7% (10-20% in most cases). Furthermore, removing the normalization of isoprene by CO 2 led to a much weaker association with FE NO that was only borderline significant. This is likely to have occurred because of the increased variance of raw exhaled isoprene compared with the CO 2 -normalized data. The implications are that other studies not performing this adjustment may have been biased. Limitations in the FE NO data are as follows. We discarded 200 mL of deadspace air before collection of breath samples for the collection of exhaled NO, but the appropriate volume of gas to be discarded is not known and likely varies from subject to subject (ATS/ERS 2005). Also, it is possible that some contamination from sinus NO occurred despite the venting of deadspace air and use of a nose clip.
Future research
Our results have shown interesting associations of exhaled isoprene with FE NO in this cohort panel, but it is difficult to extrapolate this information to a broader population because our cohort is a narrow subset of the general population. As stated in the methods section, this is a cohort of elderly subjects in an assisted living area who all have a diagnosis of coronary artery disease and are non-smokers. A similar study among a broader population, those consisting of a mixture of subjects in different age groups and with different co-morbidities (especially asthma) as well as those who are healthy, would be valuable to see if these results could be reproduced. This would help to support or contradict (as with the presented results) our original hypothesis, that exhaled isoprene would be positively associated with FE NO and may thus be a potential biomarker of inflammation.
Conclusions
Our results confirm a previous study in the larger 60-subject cohort that found FE NO to rise with increasing outdoor ozone air pollution (Delfino et al. 2010) . From these pilot data we found no supportive data that isoprene could be considered as a positive biomarker of airway inflammation due to the inverse relationship between exhaled isoprene and FE NO . However, a significant inverse association between exhaled isoprene and FE NO as well as an inverse association between exhaled isoprene and outdoor ozone suggests some potentially important chemical reactions may be occurring in the lungs. These findings also suggest interesting mechanisms as discussed regarding the potential antioxidant function of isoprene in humans although this is purely speculative. Finally, we speculate that since FE NO may be used to help diagnose asthma and to monitor asthma status in certain cases as discussed, it is conceivable that isoprene may confound that relation in some individuals with high or variable exhaled isoprene levels. The potential biochemical effects of isoprene could also have implications in the individual variation in acute asthma severity. Further research to confirm or reject the present preliminary findings is suggested, particularly in populations of subjects with and without asthma. All models are adjusted for splines of 3-day average temperature. Table 2 Distribution of variables. 
